Using sarkosyl-insoluble samples, Wesseling et al. [70] performed a quantitative and qualitative tau protein profiling (FLEXITau and Q-Exactive MS) of 29 AD patients and 28 matched control individuals. The gene discussed is MAPT; the disease is Alzheimer disease.